WINSTON-SALEM N.C. - Two American aid workers infected with Ebola in Africa while responding to an outbreak of the deadly virus have shown slight improvement but remain in serious condition, a relief organization said on Wednesday.
FREETOWN - The doctor leading Sierra Leone's fight against the worst Ebola outbreak on record died from the virus on Tuesday, the country's chief medical officer said. | Video
- Pfizer Inc agreed on Wednesday to buy Baxter International Inc's vaccines unit and a part of a production facility for $635 million.
PARIS - A new drug being developed by French drugmaker Sanofi and U.S. partner Regeneron cut "bad" LDL cholesterol more than placebo and existing treatments in nine late-stage clinical trials, the companies said on Wednesday.
- A Massachusetts jury has cleared Boston Scientific Corp of selling dangerous and defective transvaginal mesh devices, in the first out of more than 20,000 lawsuits waiting to go to trial.
NEW YORK (Reuters Health) - A recent study suggests that most elementary age students are okay with eating the healthier school lunches required by the USDA.
LONDON - AstraZeneca took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion for the rights to Spanish group Almirall's lung drugs.
NEW YORK (Reuters Health) - People who arrive at the hospital with a heart attack during business hours are more likely to survive than those who show up on weeknights, weekends or holidays, according to a new study.
NEW YORK (Reuters Health) - Many tools exist to help introduce people to the subject of advanced care planning, but they vary widely in what they offer and how accessible they are, according to a new research review.
WASHINGTON D.C. - Home genetics startup 23andMe has secured a $1.4 million two-year grant from the National Institutes of Health (NIH) to build survey tools and expand its gene database.
Video: Health Reform Watch
A series that looks at all facets of cancer, written by Debra Sherman, a lung cancer patient who succumbed to the disease on April 22, 2014. Debra covered the health beat for Reuters for more than a decade and drew on her knowledge about health, her contacts in the industry and her personal experiences to report this series. Full Article